WebBy Annabelle Liang. The Carlyle Group has bought a 20% stake in an Indian billionaire-owned pharmaceutical firm for INR 3,523.40 crores ($479.3m). The transaction involving Piramal Enterprises’ subsidiary Piramal Pharma is one of the largest private equity deals in the Indian pharma sector, the firm said in a statement. Web30 apr. 2024 · The Carlyle Group recorded a $1.2bn investment loss and said it was …
ION Investment Group Recapitalizes Dealogic, a Carlyle Portfolio ...
Web7 jan. 2024 · U.S.-based investment firm The Carlyle Group has committed $374 million … Web22 nov. 2024 · Euromoney had acquired a 15.5 percent stake in Dealogic for $59.2 … razor cuts for medium length hair
Carlyle provides about $400 mln to ION PE Hub
Web22 dec. 2024 · Carlyle to acquire TESCAN 22 December 2024, Brno, Czech republic – Global investment firm Carlyle (NASDAQ: CG) announced today that it has agreed to acquire a majority stake in TESCAN ORSAY HOLDING, a.s. (“TESCAN”), a leading manufacturer of electron microscopes and other high-tech scientific instruments. WebThe Carlyle Group (NASDAQ: CG) is a global alternative asset manager with $212 billion … Web22 nov. 2024 · The Carlyle Group (NASDAQ: CG) is a global alternative asset manager … simpson sph-6